The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
Exner, M
The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein. [electronic resource] - FEBS letters Mar 2000 - 47-50 p. digital
Publication Type: Journal Article
0014-5793
10.1016/s0014-5793(00)01289-8 doi
Arteriosclerosis--prevention & control
Aspirin--metabolism
Cells, Cultured
Diabetic Angiopathies--prevention & control
Endothelium, Vascular--drug effects
Gentisates
Glucose--metabolism
Humans
Hydroxybenzoates--metabolism
Iron Chelating Agents--metabolism
Lipoproteins, LDL--metabolism
Male
Oxidation-Reduction
Prodrugs--metabolism
Reactive Oxygen Species--metabolism
Salicylic Acid--metabolism
Thromboplastin--biosynthesis
The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein. [electronic resource] - FEBS letters Mar 2000 - 47-50 p. digital
Publication Type: Journal Article
0014-5793
10.1016/s0014-5793(00)01289-8 doi
Arteriosclerosis--prevention & control
Aspirin--metabolism
Cells, Cultured
Diabetic Angiopathies--prevention & control
Endothelium, Vascular--drug effects
Gentisates
Glucose--metabolism
Humans
Hydroxybenzoates--metabolism
Iron Chelating Agents--metabolism
Lipoproteins, LDL--metabolism
Male
Oxidation-Reduction
Prodrugs--metabolism
Reactive Oxygen Species--metabolism
Salicylic Acid--metabolism
Thromboplastin--biosynthesis